American College of Clinical Pharmacy
      Search      Cart
         

PSAP in JACCP - June 2026


Format to Purchase:
Member Price:
$29.95
Nonmember Price:
$39.95

 

PSAP in JACCP features are developed from activities presented as part of the Pharmacotherapy Self-Assessment Program (PSAP). Each feature is available for continuing pharmacy education credit and BCPS recertification credit.

Case Series: Pediatric Cough, Cold, and Influenza
This feature was developed from a learning activity in PSAP 2025 Book 3 (Behavioral Health and Pediatrics).
  • Case Series: Click here to access the case series.
Disclosures
Consultancies: Danielle Alm (Wolters Kluwer Pediatric Lexi-Comp); Rachel Meyers (Wolters Kluwer)
Grants: Ryan C. Costantino (Department of Defense); Chanel F. Whittaker (University of Maryland System – Kirwin Center for Academic Innovation)
Stock Ownership: Rachel Meyers (Takeda, Bristol Myers Squibb, Johnson & Johnson, Cohbar, Baxter, Perrigo)
Nothing to disclose: Rasha Abdelsalam Elshenawy, David Seto

 

Case Series: Pediatric Vaccinations
This feature was developed from a learning activity in PSAP 2025 Book 3 (Behavioral Health and Pediatrics).
  • Case Series: Click here to access the case series.
Disclosures
Consultancies: Chasity M. Shelton (Wolters Kluwer, Inc.)
Honoraria: Jill A. Morgan (ASHP BCPS Review Course)
Stock Ownership: Jill A. Morgan (Met Life)
Nothing to disclose: Tho H. Pham, James Yau Hon Voo
Release Date: June 08, 2026
BCPS Deadline: December 08, 2026
ACPE Deadline: June 08, 2029

Publication Year: 2026
Format: Online Test

Technical Requirements:

Contents

Case Series: Pediatric Cough, Cold, and Influenza

Case Series: Pediatric Vaccinations

Case Series: Pediatric Cough, Cold, and Influenza

Faculty

Danielle M. Alm, Pharm.D., BCPS, BCPPS
Philadelphia College of Pharmacy at Saint Joseph's University
Clinical Associate Professor - Pediatrics
Philadelphia, Pennsylvania

Reviewers

Rachel S. Meyers, Pharm.D., FPPA, BCPS, BCPPS
Clinical Professor
Department of Pharmacy Practice and Administration
Ernest Mario School of Pharmacy
Rutgers University
Piscataway, New Jersey
Pediatric Clinical Pharmacist
Pharmacy Department
Cooperman Barnabas Medical Center
Livingston, New Jersey
David H. Seto, Pharm.D., BCPS, BCPPS
Clinical Pharmacist Specialist
Department of Pharmacy Services
Phoenix Children’s
Phoenix, Arizona
Rasha Abdelsalam Elshenawy, MSc.Pharm., Ph.D., BCPS
Senior Lecturer, Post-Graduate Medicine
School of Life and Medical Science
University of Hertfordshire
Hatfield, UK
Consultant of Antimicrobial Resistance
South Centre
Geneva, Switzerland

Case Series: Pediatric Vaccinations

Faculty

Chasity M. Shelton, Pharm.D., FCCP, FNAP, BCPS, BCPPS
Associate Dean for Student Affairs
Professor
Department of Clinical Pharmacy and Translational Science
The University of Tennessee Health Science Center College of Pharmacy
Pediatric Critical Care Clinical Pharmacist
Department of Pharmacy
Le Bonheur Children’s Hospital
Memphis, Tennessee

Reviewers

Jill A. Morgan, Pharm.D., FNAP, BCPS, BCPPS
Chair and Professor
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
Baltimore, Maryland
Tho H. Pham, Pharm.D., BCIDP
Assistant Professor
Department of Pharmacy Practice
University of Arizona, R Ken Coit College of Pharmacy
Antimicrobial Resistance/Antimicrobial Stewardship Lead
Office of Healthcare-Associated Infections
Arizona Department of Health Services
Phoenix, Arizona
James Yau Hon Voo, B.S.Pharm, M.Pharm (ClinPharm), BCPS
Lead Antimicrobial Stewardship Pharmacist
Pharmacy Department
Sabah Women and Children Hospital
Kota Kinabalu, Sabah

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American College of Clinical Pharmacy is approved by BPS as a provider for the recertification of BCPS.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: The target audience includes board-certified pharmacotherapy specialists and other advanced-practice pharmacists who are involved in the clinical management of psychiatric and pediatric populations.

Contents

Case Series: Pediatric Cough, Cold, and Influenza

Activity Number: 0217-0000-26-121-H01-P
Contact Hour(s): 2.00
Activity Type: Application Based
Learning Objectives
  1. Differentiate among common pediatric respiratory illnesses such as cold, cough, influenza and COVID-19.
  2. Apply knowledge of evidence-based treatment guidelines for managing pediatric cough, cold, influenza and COVID-19.
  3. Identify high-risk symptoms of influenza in infants and determine when antiviral treatment is indicated.
  4. Evaluate the safety and efficacy of OTC medications for treating cough in children.

Case Series: Pediatric Vaccinations

Activity Number: 0217-0000-26-122-H01-P
Contact Hour(s): 2.00
Activity Type: Application Based
Learning Objectives
  1. Classify vaccines into active and passive immunity, and distinguish how each type of immunity contributes to the effectiveness of vaccines in safeguarding pediatric patients against specific diseases.
  2. Assess and select vaccines for a pediatric patient or an adult caregiver on the basis of patient-specific factors.
  3. Evaluate evidence-based information to counter myths and misinformation, and communicate effectively with hesitant parents.
  4. Evaluate techniques to minimize discomfort and anxiety, and analyze strategies for effectively managing adverse reactions.

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.